Cargando…

Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia

Detalles Bibliográficos
Autores principales:	Blanchard, Valentin, Croyal, Mikaël, Khantalin, Ilya, Ramin-Mangata, Stéphane, Chemello, Kévin, Nativel, Brice, Blom, Dirk. J., Marais, A. David, Lambert, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	LETTER
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610154/ https://www.ncbi.nlm.nih.gov/pubmed/31312765 http://dx.doi.org/10.1016/j.jacbts.2019.03.002

Ejemplares similares

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

Recurrent coronary syndromes in a patient with isolated very-high lipoprotein (a) and the prothrombin genetic variant rs1799963 (G20210A): a case report
por: Khantalin, Ilya, et al.
Publicado: (2019)

Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
por: Croyal, Mikaël, et al.
Publicado: (2022)

Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk
por: Coassin, Stefan, et al.
Publicado: (2022)

Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia
por: Ying, Qidi, et al.
Publicado: (2023)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab
por: Villard, Elise F., et al.
Publicado: (2016)

Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab
por: Chemello, Kévin, et al.
Publicado: (2020)

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Naito, Ryo, et al.
Publicado: (2022)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status
por: Dhingra, Sanjiv, et al.
Publicado: (2005)

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2022)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
por: Lin, Yahui, et al.
Publicado: (2022)

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
por: Deprince, Audrey, et al.
Publicado: (2023)

Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions
por: Couret, David, et al.
Publicado: (2021)

Link between Omega 3 Fatty Acids Carried by Lipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Hypercholesterolemia Is Associated with the Apolipoprotein C-III (APOC3) Genotype in Children Receiving HAART: An Eight-Year Retrospective Study
por: Rocco, Carlos A., et al.
Publicado: (2012)

Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice
por: Balarini, Camille M, et al.
Publicado: (2011)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy
por: Tanimizu, Hikaru, et al.
Publicado: (2023)

Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice
por: Xu, Jingyi, et al.
Publicado: (2018)

Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B
por: Williams, Katie B., et al.
Publicado: (2022)

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia
por: Connolly, Katherine D., et al.
Publicado: (2014)

Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review
por: Kattah, Laura, et al.
Publicado: (2019)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
por: Julius, Ulrich
Publicado: (2016)

Postprandial enrichment of triacylglycerol-rich lipoproteins with omega-3 fatty acids: lack of an interaction with apolipoprotein E genotype?
por: Conway, Valérie, et al.
Publicado: (2014)

Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials
por: Bays, Harold E., et al.
Publicado: (2017)

Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
por: Magistroni, Riccardo, et al.
Publicado: (2013)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
por: Koch, Manja, et al.
Publicado: (2020)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

Genetic Dissection of Tissue-Specific Apolipoprotein E Function for Hypercholesterolemia and Diet-Induced Obesity
por: Wagner, Tobias, et al.
Publicado: (2015)

Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice
por: Pei, Zouwei, et al.
Publicado: (2016)

Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
por: Vaseghi, Golnaz, et al.
Publicado: (2021)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype
por: Han, Dong Hee, et al.
Publicado: (2013)

Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease
por: Rasmussen, Katrine L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1k7gf8cik42qd9dtefoj74l460